Also, mouse models carrying a combination of Pten mutations with other oncogenic drivers such as mutant Pik3ca and Erbb2 have accelerated development of mammary tumours (Kato et al., 2020; Yip et al., 2020). This evidence concerns the gene ERBB2 and breast cancer.